Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,265 across all filing types
Latest filing 2020-08-14 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in ''''Business Standard'''' ...
Regulatory Filings Classification · 90% confidence The document contains only placeholders for images and no textual content or financial data. It is extremely short (218 characters) and does not provide any report, announcement, or detailed information. Given the lack of content, it cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2020-08-14 English
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document contains only placeholders for images and no textual content or financial data. It is extremely short (218 characters) and does not contain any report, announcement, or detailed information. Given the lack of content, it cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2020-08-14 English
Change in Director(s)
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the appointment and re-appointment of directors at the Annual General Meeting held on August 10, 2020. It includes brief profiles of the appointed directors. The content focuses on changes in the company's board of directors, which fits the category of Board/Management Information. The document length is 3644 characters, which is relatively short but contains substantive information about management changes rather than just an announcement of a report. Therefore, it is not a report publication announcement or regulatory filing. The key indicators are the appointment of directors and re-appointments approved at the AGM, which aligns with the MANG category.
2020-08-12 English
We wish to inform you that at the Company's Annual General Meeting held on August 10, 2020, the Shareholders have approved the following appointments: 1. Appointment of Mr. Ankush ....
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the appointment and re-appointment of directors at the Annual General Meeting held on August 10, 2020. It includes brief profiles of the appointed directors. The content focuses on changes in the company's board of directors, which aligns with announcements of board or senior management changes. The document length is 3644 characters, which is relatively short and does not contain financial statements or detailed financial data. Therefore, it is not an annual report or financial report but a management/board information announcement.
2020-08-12 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is dated August 12, 2020, and addresses the listing departments of BSE Limited and National Stock Exchange of India Limited. It explicitly mentions "Voting Results and Scrutinizer's Report of 41st Annual General Meeting held on August 10, 2020." The content includes detailed voting results, resolution-wise results of e-voting, number of shareholders present, and invalid votes. There is no indication of full financial statements or management discussion, but rather a formal announcement of the voting outcomes from the AGM. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial but the content is focused on voting results, not the full AGM materials or annual report. Therefore, the correct classification is DVA with high confidence.
2020-08-12 English
Pursuant to Clause 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the details regarding voting results of 41st Annual General ....
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed report of voting results and the scrutinizer's report from the 41st Annual General Meeting (AGM) of AstraZeneca Pharma India Ltd. It includes resolution-wise voting outcomes, details of shareholders present, and invalid votes. The content focuses on the official results of shareholder votes on various resolutions passed during the AGM, such as adoption of accounts, appointment of directors, dividend confirmation, and auditor remuneration. There is no indication that this is a full annual report, earnings release, or management discussion. The document is not a proxy solicitation or a report publication announcement but specifically the official voting results and scrutinizer's report following the AGM. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support a high confidence in this classification.
2020-08-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.